Facebook
X
LinkedIn
Forward
2026-28 Wisconsin Newborn Screening (NBS) Program: An Introduction
Did you know not all parent/guardians are notified of their infants' NBS results and/or needed referrals that were made/completed? This puts infants at risk. This activity is intended for pediatric clinicians who wish to improve their understanding of the NBS process, NBS rates, communication of NBS results with parent/guardians and making appropriate referrals. This activity was created by geneticists, genetic counselors, pediatricians, public health representatives and parents.
Intended Audience
MD, DO, RN, APRN, LPN, PA, Midwives, Genetic Counselors, Phlebotomists
Learning Objectives
Participants completing this CME module will be able to:
- Describe the Wisconsin Newborn Screening (NBS) program, including what conditions are included.
- Provide education to families about the NBS process and the difference between a screen and a diagnostic test.
- Define possible NBS results, identify when further action is required and identify resources for providers and families.
- Communicate with families about NBS results and next steps following borderline and positive results.
Plannning Committee
Ashely Kuhl, MS. Activity Coordinator. Genetic Counselor
Tonisha Atkins, MS/MPH. Genetic Counselor
Jess Scott Schwoerer, MD. Medical Geneticist
Wanda Meeteer, DNP, RN. Nurse Practitioner
Brooklyne Watkins, PA. Physician Assistant
Reviewers
Mandy Quianoo, MSEd. Newborn Screening Follow-through Coordinator
Mei Baker, MD. Director of Newborn Screening at WSLH
Robert Steiner, MD. Medical Director of NBS for Wisconsin's DHS
Julie Thiel, PharmD. DHS Newborn Screening Program Director
Policy on Faculty and Sponsor Disclosure
It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate and disclose all relevant financial relationships with ineligible companies* held by the speakers/presenters, authors, planners, and other persons who may influence the content of this accredited continuing education (CE). In addition, speakers, presenters, and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation.
For this accredited continuing education activity all relevant financial relationships have been mitigated and detailed disclosures are listed below.
*Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by, or on, patients. The ACCME does not consider providers of clinical services directly to patients to be ineligible companies.
| Name | Role | Financial Relationship Disclosures | Discussion of Unlabeled/Unapproved Uses of Drugs/Devices in Presentation? |
|---|---|---|---|
| Ashely Kuhl, MS. Genetic Counselor | Activity Coordinator. Planning Committee Member | No relevant financial relationships with ineligible companies to disclose. | No |
| Tonisha Atkins, MS/MPH. Genetic Counselor | Planning Committee Member | No relevant financial relationships with ineligible companies to disclose. | No |
| Jess Scott Schwoerer, MD. Medical Geneticist | Planning Committee Member | No relevant financial relationships with ineligible companies to disclose. | No |
| Wanda Meeteer, DNP, RN. Nurse Practitioner | Planning Committee Member | No relevant financial relationships with ineligible companies to disclose. | No |
| Brooklyne Watkins, PA. Physician Assistant | Planning Committee Member | QED Therapeutics (Independent Contractor - Other) Ascendis Pharma (Independent Contractor - Other) Tyra Biosciences (Independent Contractor - Other) | No |
| Mandy Quianoo, MSEd. Newborn Screening Follow-through Coordinator | Reviewer | No relevant financial relationships with ineligible companies to disclose. | No |
| Mei Baker, MD. Director of Newborn Screening at WSLH | Reviewer | No relevant financial relationships with ineligible companies to disclose. | No |
Robert Steiner, MD. Medical Director of NBS for Wisconsin's DHS | Reviewer | Astellas Pharma (Contractor), Regeneron Pharmaceuticals (Grant), Amgen (Contractor), Bridge Bio Therapeutics (Contractor), Mirum Pharma (Contractor) | No |
| Julie Thiel, PharmD. DHS Newborn Screening Program Director | Reviewer | No relevant financial relationships with ineligible companies to disclose. | No |
Accreditation Statement
 | In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. |
Credit Designation Statements
American Medical Association (AMA)
The University of Wisconsin–Madison ICEP designates this enduring material for a maximum of .75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC)
The University of Wisconsin–Madison ICEP designates this enduring material for a maximum of .75 ANCC contact hours.
Continuing Education Units (CEUs)
The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 0.075 CEUs or .75 hour.
American Board of Internal Medicine
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to .75 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
American Board of Pediatrics
Successful completion of this CME activity, which included participation in the activity, with individual assessment of the participant and feedback to the participant, enables the participant to earn .75 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.
Available Credit
- 0.75 MOC: ABIM Medical Knowledge Points (Part II)
- 0.75 MOC: ABP Lifelong Learning Points (Part II)
- 0.75 AMA PRA Category 1 Credit™
- 0.75 ANCC Contact Hours
- 0.75 University of Wisconsin–Madison Continuing Education Hours
- 0.75 Approved for AMA PRA Category 1 Credit™
Registration for this activity can only be completed through the ICEP Learning Portal. Attendee registrations made through any other sites cannot be honored. UW-Madison ICEP is not able to refund fees paid through unaffiliated registration sites, such as eMedEvents.com, MedConfWorld.com, EventEgg.com, and 10times.com. Please report any unauthorized websites or solicitations for registrations to [email protected].
Accessibility
The University of Wisconsin provides equal opportunities in employment and programming, including Title IX requirements. The University of Wisconsin fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please notify us at [email protected]
Required Hardware/software
Free, current version of Chrome, Firefox, Safari, or Edge. Some older browsers and Internet Explorer could produce error messages or not display the content correctly.
Free, current version of Adobe Acrobat Reader or other .pdf reader.